Yahoo
HKSE - Delayed Quote HKD

160 Health International Limited (2656.HK)

3.210 +0.210 (+7.00%)
As of 11:59:54 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2656.HK
  • Previous Close 3.000
  • Open 3.300
  • Bid 3.210 x --
  • Ask 3.215 x --
  • Day's Range 3.040 - 3.525
  • 52 Week Range 2.105 - 158.400
  • Volume 82,588,500
  • Avg. Volume 16,436,825
  • Market Cap (intraday) 1.115B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.220
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China. Thedevelops Healthcare 160 Platform, an online healthcare and wellness service platform which provides digital healthcare and wellness solutions, including online marketing solutions, digital hospital solutions, and online healthcare services to business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants. 160 Health International Limited was founded in 2005 and is headquartered in Shenzhen, the People's Republic of China.

www.91160.com

464

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2656.HK
94.20%
HANG SENG INDEX (^HSI)
3.79%

1-Year Return

2656.HK
92.42%
HANG SENG INDEX (^HSI)
4.92%

3-Year Return

2656.HK
89.29%
HANG SENG INDEX (^HSI)
39.60%

5-Year Return

2656.HK
89.29%
HANG SENG INDEX (^HSI)
0.85%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.61%

  • Return on Assets (ttm)

    -5.42%

  • Return on Equity (ttm)

    -78.53%

  • Revenue (ttm)

    679.95M

  • Net Income Avi to Common (ttm)

    -51.73M

  • Diluted EPS (ttm)

    -0.220

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    426.97M

  • Total Debt/Equity (mrq)

    148.83%

  • Levered Free Cash Flow (ttm)

    -155.19M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: